Introduction
Transcription of the genes necessary for galactose catabolism (GAL) in Saccharomyces cerevisiae is dependent on GAL4, a transcriptional activator that binds specifically to DNA within the upstream activating sequence for galactose (UASG). GAL4 production and activity are stringently regulated by the available sugars (Johnston, 1987) . When galactose is absent, GAL4 is inhibited by direct interaction with a regulatory protein GAL80. Upon addition of galactose an inducer is produced by GAL3, which alters the GAL4-GAL80 interaction (Leuther and Johnston, 1992) , unmasking the activation function of GAL4, resulting in induction of GAL transcription. This process is inhibited by a combination of mechanisms that promote preferential use of glucose (Flick and Johnston, 1990, 1992; Griggs and Johnston, 1991; Nehlin et al., 1991) . Upstream repression sequences (URSG) located in the promoters of most GAL genes, including GAL1,-2,-3,-4,-7 and -10 (Nehlin et al.,
Oxford University Press 1991) cause repression of transcription when glucose is present. Gene products that may be involved in URSGmediated repression include: MIGl (Nehlin et al., 1991) , URR1, URR3, URR4 (Flick and Johnston, 1990, 1992) , SSN6 and TUPI (Keleher et al., 1992) , although the requirements for repression of each GAL gene have not yet been precisely defined. The effect of these cis-acting sequences is exercized in several ways. In addition to direct repression through their own URSG, GAL4-regulated genes are also subject to control by the concentration of GAL4, which is itself likely decreased in glucose because of GAL4's URSG (Griggs and Johnston, 1991) . GAL4 transcription is decreased -5-fold in cells growing in glucose; this small change in GAL4 expression coincides with an -100-fold decrease in transcription of GAL] (Griggs and Johnston, 1991) . The presence of GAL80 also contributes to glucose repression of GAL4-regulated genes (Nehlin et al., 1991; Lamphier and Ptashne, 1992) . Elimination of GAL80 in a strain in which GAL4 is expressed from the HIS4 promoter causes 25-fold derepression in glucose of a GAL] -lacZ reporter gene lacking the URSG (Lamphier and Ptashne, 1992) . The mechanism for this effect of GAL80 is not understood, but since transcription of both GAL3 and GAL2 are decreased in glucose, the latter of which encodes the galactose permease, at least a portion of GAL80-mediated glucose repression may result from reduced availability of the inducer (Nehlin et al., 1991) . The galactose permease (GAL2) also appears to be directly inhibited by glucose (Matern and Holzer, 1977) ; since GAL2 may only be required for induction in low galactose concentrations (Tschopp et al., 1986) , this latter mechanism may not contribute significantly to the combined effect of glucose.
Several functional domains have been identified on the GALA protein. The N-terminal 100 amino acids contain a zinc-requiring DNA-binding motif (Marmorstein et al., 1992) and a region mediating the formation of dimers (Ma and Ptashne, 1987c; Carey et al., 1989) . Two regions contribute to the transcriptional activation function of GALA and are capable of activating transcription when fused independently to the DNA-binding domain (Ma and Ptashne, 1987b; Gill et al., 1990) . These regions, termed activating region 1 (ARI, residues 149-238, see Figure 1 ) and activating region 2 (AR2, residues 768-881), have a high proportion of negatively charged amino acids, a common characteristic among eukaryotic transcriptional activation domains. Interaction with GAL80 is mediated by the Cterminal 30 amino acids (residues 848-881), deletion of which renders GALA active in the absence of galactose (Ma and Ptashne, 1987a) .
A function has not previously been identified for the central region (CR) of the protein (residues 239-767, see Figure  1 ) which represents -60% of the total mass of GAL4 GAL4 derivatives. Activity of GAL4 deletion derivatives was determined by measuring ,B-galactosidase produced from a GALl-lacZ reporter gene in gaI80-yeast cells grown to mid-log phase in selective medium containing glucose. GAL4 derivatives were expressed from the ADHI promoter on a single copy plasmid vector. The GALI-lacZ reporter gene contains both the UASG and URSG. Values represent an average of at least three samples, the standard errors are indicated. GAL4-VP16 expression significantly decreases growth rate and therefore the results for derivative 1-9 are indicated in italics. Brandriss and Marczak, 1991; see Figure 9 ), which has been suggested to be involved in regulating GALA activity (Salmeron and Johnston, 1986; Johnston and Dover, 1988; Chasman and Kornberg, 1990 
Results
The central region of GAL4 inhibits transcriptional activation
Either of GAL4's activating regions (AR) can activate transcription when fused independently to the DNA-binding domain in the absence of the GAL4 central region (CR, residues 329-767) (Gill and Ptashne, 1987; Ma and Ptashne, 1987b; Gill et al., 1990) . Nevertheless, results from several previous publications have shown that the transcriptional activation function of GAL4 is severely impaired when either AR 1 (residues 149-238) or AR 2 (residues 768-881) are deleted (Ma and Ptashne, 1987b; Sadowski et al., 1991 with previous results (Gill and Ptashne, 1987; Ma and Ptashne, 1987b) , AR1 has significantly less activity than AR2 in our experiments. To determine whether the inhibitory effect of CR is specific for GAL4's activating domains, we constructed derivatives in which either AR1 or AR2 were replaced with a 77 amino acid polypeptide comprising the activating domain of herpes virus VP16 (VP16 residues 411-488) (Sadowski et al., 1988; Triezenberg et al., 1988) . Figure  1 shows that the VP16 activating domain can functionally substitute for either of GAL4's activating regions (1-5 and 1-6). However, in both instances the central region inhibits the VP16 activating domain when the remaining GAL4 activating domain is removed (compare the activities of 1-5 with 1-7 and 1-6 with 1-8). Expression of the VP16 activating domain fused independently to the GAL4 DNAbinding domain (1 -9) appears to be quite toxic to yeast cells, making quantification of its activity difficult. However, this derivative is significantly more active than either 1-7 or 1-8, both of which bear the central region, suggesting that this portion of GAL4 can indiscriminately inhibit transcriptional activation.
The two activating regions of GALA (AR1 and AR2) were initially identified by examining a nested set of C-terminal deletion mutants (Ma and Ptashne, 1987b) . These experiments generated the unusual observation that GAL4 activity was eliminated when the C-terminal 114 amino acids were removed (activating region 2), but reappeared subsequent to deletion of an additional 529 residues (central region), implying that activity of AR1 may be masked in the intact GAL4 protein, or at least in derivatives lacking AR2. The observation that either of GAL4's activating regions can be replaced with the VP16 activating region, supports the hypothesis that both ARI and AR2 contribute to transcriptional activation function of the intact GAL4 protein.
At least three segments of the GAL4 central region can inhibit transcriptional activation by activating region 2
To identify the portion(s) of CR necessary for its inhibitory effect, we created a series of internal deletion mutants to dThe results for derivative 1-9 is indicated in italics because production of this protein reduces the rate of cell growth.
identify regions that were capable of inhibiting activation by GAL4 AR2 in ga180-yeast cells grown in glucose (see Figure 2A ). We found that the major inhibitory effect is associated with GAL4 residues 238 -585. Thus, derivatives bearing residues 320-881 (2-1), 412-881 (2-2) and 554-881 (2-3), fused to the DNA binding domain, do not activate transcription, but the DNA binding domain fused to residues 585-881 (2-4) and 600-881 (2-5) are capable of activating transcription ( Figure 2A) . A further series of internal deletions indicate that there are multiple inhibitory regions within residues 238-585. Derivatives bearing the DNA-binding domain fused to residues 320-412 (2-7) or 412-478 (2-10) and AR2 have undetectable levels of transcriptional activation ( Figure 2A ). We have denoted these regions inhibitory domain 1 (ID 1) and inhibitory domain 2 (ID2) (see Figure 2A ). Although appearing to have similar effects, we were unable to identify significant structural similarity between these two regions of GAL4. selective medium containing 100 mM sodium phosphate and either glycerol (Gly) or glucose (Glu). Centre and right panels: yeast were grown to mid-log phase in minimal selective medium containing 100 mM phosphate and glycerol, at which time the cultures received an addition of 2% glucose. Samples were harvested at time 0 (Gly), 30 min (Glu 0.5 h) and 4 h (Glu 4 h) following glucose addition. Specific transcription was determined by hybridization of 32P-labelled nuclear run-on transcripts to HIS3, GALIO and lacZ DNA probes on nitrocellulose filters and quantified by scanning densitometry. The values indicated represent hybridization to the lacZ probe (centre panel) or to the GAL1O probe (right panel) as a percentage of hybridization to the HIS3 probe. HIS3 transcription did not vary by > 10% amongst the various samples. by AR1; these experiments suggest that a further inhibitory domain may reside near residues 238-320.
IDI (residues 320-412) encompasses a region of GAL4 that shares homology with a group of fungal transcriptional regulatory proteins, which include LAC9 of Kluyverormyces lactis (Salmeron and Johnston, 1986; Wray et al., 1987 ; and see Figure 9 ). To determine whether its inhibitory effect is specific for GAL4, we constructed a fusion between ID1 and a transcriptional activator consisting of Escherichia coli LexA fused to the VP16 activating domain ( Figure 2B , 2-12). LexA derivatives were assayed in a gal80-yeast strain bearing a reporter gene consisting of six lexA operators upstream of a GAL] -lacZ fusion, which was deleted of both the UASG and URSG (Ruden et al., 1991) . Figure 2B shows that ID 1 strongly inhibits transcriptional activation by LexA -VP16 of this reporter gene (compare the activity of 2-12 with that of 2-13), suggesting that the inhibitory function of ID1 does not require the DNA-binding domain of GAL4, or apparently the URSG of the GALI promoter.
The central region is required for direct inhibition of GAL4 by glucose As outlined in the Introduction, several mechanisms have previously been identified for repression of galactoseinducible genes by the presence of glucose. The primary mechanisms for glucose repression appear to involve: inhibition of GAL4 transcription (Griggs and Johnston, 1991) , inhibition by upstream repression sequences (URSG) (Flick and Johnston, 1990; Griggs and Johnston, 1991; Nehlin et al., 1991) and an uncharacterized effect that requires the presence of GAL80 (Nehlin et al., 1991; Lamphier and Ptashne, 1992) . In the experiments shown in Figures 1 and  1378 2A these inhibitory mechanisms have been eliminated, apart from any repression mediated by the GAL] URSG. GAL4 derivatives are expressed at higher than normal levels from the ADH1 promoter in a gal80-yeast strain; under these conditions activity of wild type GAL4 is unaffected by the presence of glucose (not shown). Nevertheless, since the central region of GAL4 appears to have a strong inhibitory effect in cells grown in glucose, we questioned whether GAL4 activity may be directly inhibited by glucose through the action of the central region. In support of this notion, we invariably find that for GAL4 derivatives bearing only a single activating domain, the presence of the central region significantly reduces their ability to activate transcription of the GAL] -lacZ reporter gene when expressed in glucose relative to when expressed in glycerol. These observations are outlined in Table I . Transcriptional activation by ARI, when fused independently to GAL4's DNA-binding domain, is inhibited 17-fold by the presence of glucose, but transcriptional activation by a derivative bearing the DNAbinding domain fused to both ARI and CR is inhibited 82-fold by glucose. Similarly, a derivative bearing both CR and AR2 is inhibited 34-fold by glucose, but when GAL4(1-147) is fused independently to AR2 it is inhibited only 6-fold. It could be argued from these observations that the presence of the central region merely weakens the activation strength of GAL4 derivatives and therefore renders them more sensitive to glucose inhibition mediated by the URSG in the GAL] promoter. However, we also find that very strong transcriptional activators bearing the VP16 activating domain, when fused to the central region, are also sensitive to inhibition by glucose. Transcriptional activation of the GAL] -lacZ reporter gene by GAL4-VP16 (1-9) is not inhibited by glucose, but transcriptional activation by derivatives bearing CR fused to either the C-terminus (1-7) (.-galactosidase activity was assayed in cells grown to mid-log phase in either glycerol (GLY) or glucose (GLU). B. Deletion of the glucose response domain constitutively inactivates GAL4. GAL4 derivatives were expressed from the ADHI promoter on a single copy plasmid vector in yeast strain YT6::171. ,B-galactosidase activity was assayed in cells grown to mid-log phase in glycerol.
or N-terminus (1-8) of VP16 are inhibited by the presence of glucose (Table I) .
To determine whether we could detect inhibition of GALA activity by the presence of glucose and whether the central region is required for this inhibition, we assayed transcriptional activation by GAL4 under conditions in which all other known glucose repression mechanisms were eliminated. The experiments shown in Figure 3 were performed in a gal4-gal80-yeast strain bearing a GALI-lacZ reporter gene (SV15), deleted of both the UASG and URSG (Flick and Johnston, 1990 ) and which contains a single strong consensus GAL4 DNA-binding site (Giniger et al., 1985) . Additionally, we expressed GAL4 from the phosphate-repressible PHOS promoter (Meyhack et al., 1982) on a single copy plasmid vector to ensure that GAL4 was produced at lower levels than with the ADHI promoter, but at equivalent levels in cells growing in glycerol and glucose. In these experiments, we found that transcriptional activation of ,B-galactosidase expression by wild type GAL4 was repressed only -2-fold in cultures grown in the presence of glucose relative to cultures grown in glycerol (Figure 3 , SV15 GALJ-lacZ, left panel). However, under the same conditions activity of a GAL4 derivative lacking the central region, but bearing both ARI and AR2 (GAL4ACR), is significantly less than that of wild type GAL4, but is not inhibited by glucose. Surprisingly therefore and despite the fact that the central region appears to contribute significantly to glucose inhibition of GAL4 derivatives bearing a single activating region (Table I) , activity of wild type GAL4 appears to be much less sensitive to growth in the presence of glucose. Furthermore, all direct inhibition of wild type GAL4 activity by glucose can be eliminated by expression at high levels from the ADHI promoter (not shown), whereas activity of GAL4 derivatives bearing the central region and only a single activating region appear to be inhibited by glucose even when expressed at high levels (Table I , data not shown, and see below). We attribute this apparent discrepancy to the fact that wild type GAL4 binds highly cooperatively to multiple adjacent sites on DNA (T.Kang, T.Martins and I.Sadowski, in preparation). Cooperative DNA binding requires a C-terminal region of GAL4 that overlaps at least a portion of the central region and is a function that is likely disrupted in the GAL4 deletion derivatives. If glucose were to act by inhibiting binding of GAL4 to DNA, a possibility we discuss in more detail below, then direct glucose inhibition of wild type GAL4 produced at higher levels could easily be offset by cooperative DNA binding. Cooperativity must be mediated by interaction between GAL4 dimers; therefore it is possible that the single strong binding site of the SV15 GAL] -lacZ reporter gene is bound by an aggregate of GAL4 dimers or cooperativity forces binding to an adjacent cryptic binding site when expressed at high levels (see Discussion).
To examine directly inhibition of transcriptional activation by GAL4 and to determine the immediate effect of glucose addition, we assayed nuclear run-on transcription of the SV15 GALl-lacZ reporter construct and the endogenous GAL10 gene, 30 minutes and 4 h following addition of 2% glucose. Figure 3 shows that lacZ transcription (SV15 GALJ-lacZ, centre panel) is repressed -7-fold within 30 min following addition of glucose to yeast expressing WT GAL4, but is not repressed in yeast expressing GALAACR. Similarly, 30 min following glucose addition, transcription of the endogenous GALIJO gene (GALIO, right panel), which also may be subject to regulation by a URSG (Flick and Johnston, 1990; Nehlin et al., 1991) Figure 1 , were grown to mid-log phase in selective medium containing glycerol, at which time glucose was added to 2%. 2 h later, the cells were harvested and labelled for 90 min with
[35S]methionine in medium containing 2% glucose. The yeast were then lysed and the proteins immunoprecipitated with specific antibodies against GAL4(1-147). All derivative proteins were either left untreated (-) or were treated with phosphatase (+) prior to analysis on 10% SDS-polyacrylamide gels. Immunoprecipitates of WT GALA and derivative 1-10 were analysed directly, while the remaining derivatives were reimmunoprecipitated prior to electrophoresis to eliminate co-precipitating proteins.
GAL4 Derivative 1-2 2-1 2-2 2-5 2-4 2-6
Phosphatase -+ -+ -+ -+ -+ -+ protein bearing GAL4 CR fused to the C-terminus of LexA -VP16 is inhibited -40-fold by glucose ( Figure 4A , 4-1). Response of LexA-VP16-GAL4 hybrids to glucose is dependent on the presence of the full GALA central region (residues 236-768). Derivatives bearing only the inhibitory domains, identified as described in Figure 2, Figures 5, 6 and 7, the immunoprecipitated proteins were visualized by autoradiography of SDS -PAGE gels. Immunoprecipitations of derivatives 1-2, 1-3, 1-4 and 4-9 have been presented in previous publications (Gill et al., 1990; Sadowski et al., 1991) . Each of the GAL4 and LexA derivatives are detectable in yeast labelled in the presence of glucose, suggesting that those that are inactive as transcriptional activators must be inhibited rather than selectively degraded, destabilized or under-produced. In fact, several of the smaller inactive derivatives, such as 2-9 and 2-1O (Figure 6 ), are expressed 2-7 2-10 2-9 4-7 4-6 ;2-3 2-!~4-8 97 -68 -43 - Fig. 6 . Immunoprecipitation of GALA internal deletion derivatives. GALA derivative proteins were isolated from labelled yeast as described for Figure 5 . All derivative proteins were either left untreated (-) or were treated with phosphatase (+) prior to analysis on 10% SDS-polyacrylamide gels. Immunoprecipitates of derivatives 2-3, 2-8 and 4-8 were analysed directly, while the remaining derivatives were reimmunoprecipitated prior to electrophoresis. at very high levels, but do not activate transcription ( Figure 2) . Similarly, immunoprecipitations of most derivatives contain little if any degraded GAL4 or LexA protein. One exception appears to be derivative 2-4 ( Figure 6 ), which is capable of some transcriptional activation (Figure 2 ). Derivative 1-10 consistently migrates on SDS -PAGE as multiple species that are unaffected by phosphatase treatment ( Figure 5 ). These multiple species may result from degradation or a modification other than phosphorylation.
In a previous publication we presented evidence that some phosphorylations of GAL4 may occur as a consequence of transcriptional activation (Sadowski et al., 1991) ; this conclusion is supported by the immunoprecipitations shown in Figures 5 and 6 . All GAL4 deletion derivatives bearing AR2 that activate transcription have at least one phosphorylated species, but those that are inactive, with two exceptions, are unphosphorylated. Thus for example, we cannot detect phosphorylated forms of derivatives 2-1, 2-2 and 2-3, all of which are completely inactive, despite the fact that these proteins bear all of the sequences present in derivatives 2-4 and 2-5, both of which activate transcription and are phosphorylated ( Figure 6 ). Two inactive derivatives 2-9 and 2-10 were found to have phosphorylated species; although we do not know the location of these phosphorylations, we suspect they may result from the high level at which these two derivatives are expressed (see Figure 6 ). For reasons we do not completely understand, it is generally more difficult to detect phosphorylated species of LexA derivatives (Figure 7 ). Perhaps this reflects the fact that there are likely to be less sites on the yeast chromosome from which the LexA derivatives can activate transcription.
Discussion
Our results suggest that GAL4 is directly inhibited by the presence of glucose, a response that requires the large central region of GAL4 located between activating regions 1 and 2, for which a function has not previously been identified. The central region contains multiple segments between residues 238-600 (ID1, ID2, between residues 320-520, within the region we have identified as having an inhibitory function, result in inactivity of the GAL4 protein (Johnston and Dover, 1988) . Because a function had not previously been described for the central region, the effect of these mutations on GAL4 was unknown. It is possible in the context of our model that these mutations disrupt interaction of the inhibitory domains with the GRD, resulting in constitutive inhibition.
Other evidence suggests that glucose inhibition of GAL4 activity may involve modulation of DNA binding. Giniger et al. (1985) glucose inhibits GAL4 transcription (Griggs and Johnston, 1991) . Others have previously shown that glucose repression can be overcome by small increases in the cellular concentration of GAL4 (Griggs and Johnston, 1991; Lamphier and Ptashne, 1992) , a result consistent with our own observations. We find that direct glucose inhibition of wild type GAL4 activity in particular is more pronounced at lower levels of expression. Fig. 9 . A family of related transcriptional activator proteins share homology with the GALA central region (Salmeron and Johnston, 1986; Wray et al., 1987; Chasman and Komberg, 1990; Brandriss and Marczak, 1991) . Shown are schematic representations of GAL4 and a group of GAL4-related proteins from S.cerevisiae (S.c.) and Klactis (Kl1.), each of which share regions of homology with the zinc-requiring DNA-binding motif (C2C2 Zn Motif) and with IDI of GAL4 (shaded). GALA and LAC9 also have regions with homology at their C-termini, which mediate interaction with a negative regulator (Regulatory Protein Interaction). Each member of this group regulates transcription of a group of genes (Regulon), whose products are components of a common anabolic or catabolic pathway. The metabolic precursors of these pathways are known to stimulate activity of the corresponding transcriptional activator proteins (+Signal). Additionally, activity of GAL4 and LAC9 when placed immediately adjacent to the DNA-binding domain (compare 2-13, Figure 2 , and 4-2, Figure 4 , and data not shown).
Our results suggest that the central region inhibitory function is most effective shortly after glucose addition, implying that if inhibition were mediated by decreased DNA binding, then DNA-bound GAL4 would have to be displaced upon addition of glucose. While we have no direct evidence for such a displacement, we have preliminary results that suggest LexA derivatives bearing the central region bind more weakly to a LexA operator when extracted from yeast grown in glucose (G.Stone and I. Sadowski, unpublished) . If DNA binding of GAL4 were not affected by glucose, then one would have to argue that the inhibitory domains of DNAbound GAL4 attracted a protein that antagonizes GALA function in cells growing in glucose. Such an inhibitory protein could function in a manner analogous to GAL80, which prevents activation by GAL4 in cells growing in the absence of galactose. Experiments designed to differentiate between these possibilities are in progress.
There are several possible mechanisms by which glucose could confer regulation on GAL4. Glucose or a metabolite (Flick and Johnston, 1990) could bind directly to GAL4 or to a regulatory protein, causing a conformational change. Alternatively, GAL4 or a regulatory protein could be posttranslationally modified in response to glucose. Mylin et al. (1990) have shown that GAL4 is dephosphorylated in the presence of glucose. However, since we have previously shown that some phosphorylation of GAL4 may occur as a consequence of transcriptional activation (Sadowski et al., 1991) , it is difficult to distinguish between loss of phosphorylation due to inhibition of activity and loss of activity due to dephosphorylation. Our results suggest that the phosphorylated species we routinely observe on SDS -PAGE gels are probably not directly involved in response to glucose. In general, these species only appear under conditions in which GAL4 can activate transcription. The results of Figure 6 suggest that at least two phosphorylations on GAL4 reside within the C-terminal 280 amino acids, we have located one of these at Ser837 (Sadowski et al., 1991) . We find that derivatives capable of activating transcription, even when labelled in the presence of glucose, have at least one of these phosphorylations (see Figure 6 , 2-5). However, the same phosphorylations are not present on inactive derivatives when labelled under identical conditions ( Figure 6 , 2-1, 2-2).
GAL4 shares sequence identity in its central region with a group of fungal transcriptional regulatory proteins, including LEU3 (Zhou et al., 1987) , PPR1 (Kammerer et al., 1984) and PUT3 (Brandriss and Marczak, 1991) of S. cerevisiae and LAC9 (Salmeron and Johnston, 1986 ) of K. lactis; the strongest sequence conservation between these proteins, apart from the DNA binding motif, occurs between residues 320-4 12 of GAL4 (Salmeron and Johnston, 1986; Wray et al., 1987; Chasman and Kornberg, 1990; Brandriss and Marczak, 1991; see Figure 9 ), a region we have identified as having a negative effect upon transcriptional activation (ID 1). Each of these transcriptional regulatory proteins is responsible for controlling expression of groups of genes, all of which are components of a common anabolic or catabolic pathway. In each case, activity of the transcriptional regulatory protein is known to be stimulated by the presence of the metabolic precursor of the pathway ( Figure  9 ). GAL4 and LAC9 are subject to additional negative regulation by glucose. That our data suggest this region of identity may be involved in negative regulation is consistent with studies of other members of this family. Large deletions of the central portion of LEU3 are known to render the protein constitutively active (Friden et al., 1989) . LEU3 may be negatively regulated by its ID region of homology; the inhibitory effect may be antagonized in the presence of a-isopropylmalate. Additionally, we have shown that the region of LAC9 bearing sequence identity with IDl of GALA inhibits activation by LexA-VP16 (G.Stone and I. Sadowski, unpublished) .
Transcription of the GAL genes in yeast are strongly and rapidly repressed in the presence of glucose by a combination of mechanisms. The promoters of most galactoseinducible genes and the GAL4 gene itself have upstream repression sequences (Flick and Johnston, 1990, 1992; Griggs and Johnston, 1991; Nehlin et al., 1991) , which cause direct inhibition of transcription in response to glucose. The product of the MIGI gene appears to be a glucosedependent repressor that is required for URSG repression (Flick and Johnston, 1990; Griggs and Johnston, 1991; Nehlin et al., 1991) . Import of galactose into the cell by GAL2 is also directly inhibited by glucose (Matern and Holzer, 1977) . The combined effect of decreased GAL2 activity and reduced transcription of both GAL2 and GAL3 in glucose would likely result in reduced availability of an inducer (Nehlin et al., 1991) . However, GAL80 also appears to mediate an additional effect of glucose that cannot be accounted for by the effects on GAL2 and GAL3 (Nehlin et al., 1991; Lamphier and Ptashne, 1992) . A previous report demonstrated that when both GAL80 and MIGI are disrupted, GAL] and GAL2 transcription are reduced only -2-fold in cultures grown in glucose (Nehlin et al., 1991 (Ruden et al., 1988) . Evolutionary conservation of at least portions of this region implies that the combined effect of these functions is critical for the physiological role of GAL4.
Materials and methods
Yeast strains and ,6-galactosidase assays All experiments were performed with yeast strain YT6 (Himrelfarb et al., 1990 ) (MA Ta gal4 gal8O ura3 his3 ade lys2 trpl aral leu2 met), bearing (Giniger et al., 1985) or six LexA operators (Ruden et al., 1991) at -130, respectively. Transcriptional activation by GAL4 and LexA derivatives was measured by assaying fl-galactosidase activity in cells grown to mid-log phase in minimal selective media, as described by Himmelfarb et al. (1990) . In all experiments, glycerol grown cultures contained 2 % v/v glycerol, lactic acid and ethanol, while glucose grown cultures contained 2 % w/v glucose and 2 % v/v glycerol, lactic acid and ethanol. Plasmids Most plasmids for expression of GAL4 and LexA derivatives were derived from pMH76 (Sadowski et al., 1992) , a single copy vector in which GAL4 (WT, Figure 1 ) is expressed from the ADH1 promoter, with transcripts terminated within the ADH1 terminator. The residues present in the GALA and LexA derivatives (Figures 1, 2 and 4 ) and the residues encoded by the fusion junctions are shown in Table II. GAL4 deletion derivatives. Plasmids expressing GAL4 derivatives 1 -1, 1-2, 1-3, 1-4 and 4-9 have XhloI-HindIJI backbones from pMH76, with XhoI-HindII1 inserts from pKW1 (Sadowski et al., 1991) , pCD21XX, pMA236, pMA246 and pMA242 (Ma and Ptashne, 1987b) , respectively. Derivative 2-2 was constructed by digesting 1-1 with EcoRI, which cleaves between the coding sequences for GAL4(1-147) and CR, and with SalI, which cleaves at codon 547; the ends were religated using an adapter (5'-AATTCTCGAG-3'). Plasmids encoding derivatives 2-1, 2-3, 2-4 and 2-5 were generated by cutting derivative 1-1 with EcoRl, followed by digestion with Bal31. The ends were ligated to an EcoRI linker (5'-GGAATTCC-3'), following treatment with Klenow. In-frame fusions of these deletions encoding C-terminal portions of GAL4 were then created with GALA(1-147) by cloning EcoRI-HindIH fragments into the vectors pYl, pY2 and pY3 (Sadowski et al., 1992) . To facilitate fusion of GALA AR2 to several deletion derivatives, a BamHI site was introduced at GALA codons 767-768 by oligonucleotide directed mutagenesis; this mutation has no apparent effect on GALA activity (not shown) and was subsequently 1384 introduced into derivatives 1-1 and 2-1 to form 1-IBam and 2-IBam, respectively. Derivatives 2-6 and 2-7 were then created by digesting 1-l"am and 2-lBam with Sall-BamHI and the vector ends ligated together using an adapter consisting of two oligonucleotides (5'-TCGAGG-TGG-3',5'-GATCCCACC-3'). To create derivatives 4-6, 4-7 and 4-8, XzoI-EcoRI inserts from pCD56X, pCD38XX and pCD52XX (Ma and Ptashne, 1987b) were first ligated to an X7oI-EcoRI backbone of derivative 4-9. A BamHI adapter, 5'-AATTGGATCC-3' was ligated into the EcoRl sites of these intermediate constructs to generate in-frame fusions of CR with AR2. Derivatives 2-8, 2-9 and 2-10 have a Sall -HindIl backbone from derivative 2-2, and SaI-HindIH inserts from derivatives 4-5, 4-6 and 4-7, respectively.
PH05-GAL4 expression plasmids. Plasmids expressing GAL4 from the PH05 promoter were derived from pML315 (generously contributed by Mark Lamphier), a derivative of pMA448 (Ma and Ptashne, 1987a) , in which the GAL4 promoter has been replaced with the PH05 promoter. Plasmid YCpPH05-GAL4 (see Figure 3 ) has a BamHI-HindIll fragment from pML315, containing the PHO5 promoter and GAL4 coding sequence, cloned into YCplac22 (Gietz and Sugino, 1988) . YCpPH05-GAL4ACR (see Table 11 ) was constructed by sub-cloning an XhoI-MluI fragment from pMA242 (Ma and Ptashne, 1987b) into YCpPH05-GAL4.
GAL4-VP16fusion derivatives. DNA encoding the VP16 activating domain was derived from plasmid pSGVPA488, which contains a Sail -BamHI fragment , encoding VP16 amino acids 411-488, cloned blunt into the Snal site of pSG424 (Sadowski and Ptashne, 1989) . To insert the VP16 activating domain in place of GALA ARI, a linker containing an XhoI site (5'-AATTGGCCTCGAGGCC-3') was first inserted into the EcoRI site of derivative 1-1. An XhoI fragment encoding GALA residues 74-147 from this intermediate was then replaced with an XhoI-Sail fragment from pSGVPA488 to form derivative 1-5. Several GALA-VP16 derivatives were derived from pKW21 (generously provided by Kristen Wood), which has the same backbone as pYl (Sadowski et al., 1992) , but the polylinker following the coding sequence for GAIA(l -147) contains restriction sites for EcoRI, PstI, Sail and XbaI. Derivative 1-9 was wr 1-1 1-2 1-3 1-4 1-5 1-6 1-7 1-8 1-9 1-10 2-1 2-2 2-3 2-4 2-5 2-6 2-7 2-8 2-9 2-10 2-11 2-12 2-13 4-1 4-2 4-3 4-4 4-5 4-6 4-7 4-8 4-9
Glucose inhibition of GAL4
constructed by cloning an EcoRI-Sall fragment, encoding VP16 amino acids 411-488, from pSGVPA488 into pKW21; to facilitate subsequent cloning steps, the Sall site was destroyed by digestion and end-filling with Klenow. Derivative 1-6 contains an X)oI-EcoRI backbone from derivative 1-9 and XhoI-EcoRI insert from 1-2. Derivative 1-7 contains a Sall-HindHI backbone from 1-5, and SalI-HindlJ insert from 1-2. To construct 1-8 and 1-10, the XhoI-Sall fragments, spanning GAL4 codons 74-478 of derivatives 1-6 and 1-2, respectively, were replaced with that of derivative 1-1.
LexA -VPJ6 fusion derivatives. The LexA coding sequence was derived from plasmid pLexA(1 -202) +PL (Ruden et al., 1991) , which contains on a 2 Am yeast vector, the ADH1 promoter directing the expression of lexA (amino acids 1-202), the coding sequence for which is followed by a polylinker and ADH1 terminator. To generate derivative 2-11, the GAL4 coding sequence of pMH76 (WT) was replaced with the lexA coding sequence and polylinker from pLexA(I -202) +PL by exchanging SphI fragments, which cuts within the ADH1 promoter and terminators in both plasmids. Derivative 2-12 was constructed by inserting a Bglll-BamHI fragment encoding VP16 amino acids 411 -490 from pCRF2 into the BamHI site of derivative 2-11. A fragment encoding GALA IDl was generated by PCR from WT GAL4 DNA using the primers 5'-GGAATTCCTCGAGTCAGGTTC-3', and 5'-CGGGATCCGAAG-AAGGGAAG-3', this fragment was digested with EcoRI and BamHI, and cloned following the lexA coding sequence into 2-11. Derivative 2-13 was then constructed from this intermediate by inserting a Bgll-BamHI fragment encoding VP16 amino acids 411-490 from pCRF1 into the BamHI site following IDI. Derivative 4-1 consists of an EcoRI backbone from 2-11 and EcoRI insert from 1-7. DNA encoding the C-terminal portion of the GAL4 central region was removed by cutting with Sall and re-ligating the backbone to generate derivative 4-2 and by cutting with SailI and ligating in a Sall-XhoI insert from 4-5 to generate 4-3. A fragment encoding the glucose response domain was generated using derivative 1 -IBam as a template for PCR with oligonucleotides 5'-GGAATTCCCTGAGAATAACG-3' and 5'-TATCAG-CAATATTCCCAC-3'; the PCR fragment was digested with EcoRI and BamHI, and cloned into 2-11 forming derivative 4-5. An EcoRI fragment from pSGVPA488 encoding VP16 amino acids 411-488 was then inserted to form 4-4.
Other plasmids. Hybridization templates for measuring nuclear run-on transcription (see Figure 3) were cloned into pSP72 as follows: HIS3, 1.4 kb BamHI fragment from pYF92 (Storms et al., 1979) ; GALIO, 1.6 kb fragment from pNN77 (St John et al., 1981) ; lacZ, 3 kb fragment from pCH1 10 (Hall et al., 1983) .
Metabolic labelling and immunoprecipitations Labelling of cells expressing GAL4 derivatives was as described previously by Sadowski et al. (1991) , except that cultures were grown to mid-log phase in minimal selective medium containing glycerol; 2 hours prior to labelling, glucose was added to 2%. The cells were harvested and labelled in the presence of 2 % glucose, lysed and proteins immunoprecipitated as described by Sadowski et al. (1991) using GAL4-or LexA-specific polyclonal rabbit antibodies. The immunoprecipitates were suspended in 50 !d 1 x SDS sample buffer and analysed by electrophoresis on SDS-polyacrylamide gels and autoradiography or were diluted with 1 ml SDS-free RIPA buffer and reimmunoprecipitated to remove co-precipitating proteins prior to analysis by SDS-PAGE. Phosphatase treatment of immunoprecipitated proteins was as previously described by Sadowski et al. (1991) .
Nuclear run-on transcription Cells for nuclear run-on transcription assays were grown to mid-log phase in 10 mn of minimal selective media containiing glycerol, at which time 1 ml of 20% glucose was added to appropriate samples. 30 min and 4 h later, cultures were poured into Corex centrifuge tubes containing crushed ice. The cells were collected by centrifugation and nuclear run-on transcription for each sample performed as described by Warner (1991) . Labelled RNA was hybridized in 2 mi hybridization fluid (2 xSSC, 50% formamide, 0.2% SDS, 1 xDenhardt's, 60 000 c.p.m./ml) at 42°C for 72 h with nitrocellulose dot blots containing 5 yg denatured template DNA (see above, other plasmids). The filters were washed and exposed to pre-flashed X-ray film overnight. Labelled hybridized RNA was quantified by scanning densitometry.
